1.
Mancino P, Falasca K, Ucciferri C, Pizzigallo E, Vecchiet J. USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS. Mediterr J Hematol Infect Dis [Internet]. 2010 Mar. 26 [cited 2022 Aug. 9];2(1):e2010003. Available from: https://mjhid.org/index.php/mjhid/article/view/2010.003